remain equal-weight weak underli
fundament reflect valuat
ep miss cost-cut kkr deal stock declin follow
ep miss driven signific oper de-lever in-lin sale
result result ep far consensu bigger
focu announc deal term kkr cover michael cypri
come high cost term sell major
stake keep wella profession beauti
retail hair busi kkr enterpris valu billion
ebitda note far press report back march
fed bull expect larg proce alway view unrealist
still chang post covid world view time trail ebitda fair
multipl howev deal term kkr costli
convert high coupon combin anoth
convert expect wella deal close would result share
dilut strike price deal somewhat necessari
lower leverag net proce deal end total
convert jv tax vs level today
certainli expens also announc separ increment
cost-cut program total program net basi
assum approxim reinvest net increment
prior program two-third new program increment howev
increment cost-cut still design mere return prior lt
mid-teen margin target albeit potenti lower revenu base
also suspend dividend april miss
new deal term reduc ep estim
strateg partnership kkr profession sale announc
strateg partnership global invest firm kkr invest
convert prefer share coupon convert
share equat premium close stock price
may addit kkr sign memorandum understand
mou sale major stake kkr coti profession
household person unit state america
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
beauti retail hair busi includ wella clairol ghd
brand togeth wella contempl enterpris valu billion
ebitda brand gener sale
ebitda previous covid assum multipl
transact well bull high teen although surpris
lower multipl given chang environ post covid
carv wella stand-alone compani kkr acquir
stake retain remain sign wella
transact kkr also make increment convert prefer invest
intend use proce de-lever balanc
sheet invest core portfolio retain mass beauti busi
brazil action total would drive cash proce
proce jv kkr convert prefer invest
tax expect sign agreement end may
close deal month sign
turnaround announc expand turnaround plan includ
plan reduc fix cost net reinvest next
month save increment origin turnaround
plan save ebit context
expect increas one-tim cash cost associ cost reduct
program given capit gain potenti restructur abil
util one-tim cash cost remain previous
announc turnaround plan spent subject
effici highlight improv low util rate network
pare complex portfolio sku increas speed market
hope improv key prioriti compani also target
 cp reinvest save make spend effect
well busi servic reduc cot real estat
pare extern servic project target decreas vs
baselin call note save come
come remain realiz
suspend dividend announc suspend dividend april
later date reach leverag ratio coti ltm
net debt/ebitda ratio increas report ratio dec
recent amend credit agreement includ waiver
leverag coven next four quarter calcul
time net ebitda post deal ex equiti incom
call detail call highlight key growth platform current
environ includ e-commerc kyli beauti mass beauti
busi near-term growth opportun given signific
disrupt luxuri channel salon despit headlin top-line pressur
highlight number green shoot portfolio strong innov
result clean-label launch covergirl salli hansen success
fragranc launch boss aliv ck everyon e-commerc growth
mass beauti growth us top four retail last
eight week strong result intern market share growth
improv covergirl salli hansen clairol us last five
week vs latest year addit launch kyli skin europ
month anticip success roll-out howev overal result clearli
signific pressur expect continu pressur april may
potenti recoveri june anticip show
sustain sign recoveri although yet return normal given
substanti oper de-lever experienc quarter much
call focus compani cost includ non-recur covid relat
charg fx transact loss excess obsolesc spike
idl plan cost outlin plan reduct fix cost
see detail note reduct target
make effici focus end end suppli adapt demand
flexibl cost reduct ensur fit growth
reduct busi servic cut discretionari spend
ration save reinvest focu
make simpler organiz simplif review
ep consensu ep
consensu estim signific oper de-lever in-lin revenu drove
gross profit miss signific oper profit miss
profit result far consensu estim organ sale growth fell
in-lin recent pre-releas guidanc organ sale
declin includ march driven broad-bas
weak asia pacif post adjust gross profit
consensu gross margin decreas bp y-o-i due covid-rel
sale declin increas excess obsolesc expens underutil
expens tie shutdown manufactur plant oper incom
weak due lower sale gross profit fix cost de-lever
neg fx partial off-set lower cp expens
pressur china travel retail march well closur
global depart store perfumeri specialti retail consum beauti
fell y-o-i organ basi traffic mass retail drugstor
global declin consum shift purchas essenti
person care categori profession decreas y-o-i organ basi
driven salon closur march impact hair nail product line
partial off-set growth ghd strong e-commerc busi across
divis e-commerc grew dd region america
prestig brand sale declin mass brand declin mid-
teen partial off-set demand shift e-commerc emea declin
driven lockdown europ middl east march asia pacif
given pandem china travel retail although begun
see improv sale trend china cours april
particularli skincar fragranc categori still pressur asia
pacif weaken start quarter given china travel retail
pressur rest coti busi weaken march corpor sale
outlook previous withdrawn previous announc march
withdrew guidanc due volatil relat
pandem call confirm mid-teen oper margin target
much lower ep estim miss new deal term
reduc ep estim price target
also come
valuat look fair reect mute top-line growth visibl
pt deriv base ep discount peer given
expect organ top-line sever impact coronaviru pressur declin
expect gradual improv slight
organ sale growth well peer
sever near-term impact
earn visibl high leverag
earn visibl high leverag
trade valuat discount
attract beauti peer believ
earn visibl high net debt/ltm
declin augment volum upsid
earli resolut coronaviru
sharp top-line declin organ top-line
sever impact coronaviru pressur
declin estim
return lsd growth
organ sale declin continu
continu margin pressur particularli
luxuri profession busi
remain close experi reduc foot
synergi upsid
bp volum downsid
synergi downsid
synergy/cost save realiz kyli deal
impact beauti category/suppli
china india
view explan region hierarchi
research highest favor quintil
higher expect synergy/cost save
realiz licens chang upsid
lower synergi realiz kyli deal delay
deal sign close suppli chain risk shelf
space loss consum beauti consum
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
sale
sale
sale bp chang
sell gener admin
sale
sale bp chang
cost relat acquisit activ
restructur busi realign cost
provis incom tax
net incom minor
net incom non-controlling interest
ep dilut w/ kkr prefer dilut
cash equival
accru expens current liabil
incom tax payabl
pension post-employ benefit
common prefer stock
depreci amort
increas decreas oper work capit
accru expens liabil
provid oper
acquisit businesses/intag asset
use invest
net increas decreas short-term debt
net increas decreas long-term debt
proce sale common stock
net proce issuanc common stock
acquistions/distribut nci
net proce stock option transact
excess tax benefit stock option
purchas treasuri share
use financ
provid discontinu oper
effect exchang rate
net increas decreas
equiv beg
equiv end
